0.8709 USD
-0.03 (-2.95%)
0.86 USD
-0.01 (-1.25%)
Overall DCGO gets a fundamental rating of 3 out of 10. We evaluated DCGO against 100 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for DCGO as it has an excellent financial health rating, but there are worries on the profitability. DCGO has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year DCGO has reported negative net income.
DCGO had a positive operating cash flow in the past year.
Of the past 5 years DCGO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -14.58%, DCGO is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -19.07%, DCGO is doing worse than 65.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of DCGO has declined.
In the last couple of years the Operating Margin of DCGO has declined.
DCGO's Gross Margin of 31.21% is in line compared to the rest of the industry. DCGO outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
DCGO has a worse debt/assets ratio than last year.
2.2 Solvency
DCGO has an Altman-Z score of 1.27. This is a bad value and indicates that DCGO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.27, DCGO is doing worse than 68.00% of the companies in the same industry.
DCGO has a debt to FCF ratio of 0.32. This is a very positive value and a sign of high solvency as it would only need 0.32 years to pay back of all of its debts.
DCGO has a better Debt to FCF ratio (0.32) than 93.00% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that DCGO is not too dependend on debt financing.
DCGO has a better Debt to Equity ratio (0.04) than 81.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 1.27 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
A Current Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
DCGO has a Current ratio of 2.59. This is amongst the best in the industry. DCGO outperforms 82.00% of its industry peers.
A Quick Ratio of 2.59 indicates that DCGO has no problem at all paying its short term obligations.
The Quick ratio of DCGO (2.59) is better than 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -194.14% in the last year.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
The Revenue for DCGO has decreased by -47.03% in the past year. This is quite bad
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
3.2 Future
The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
The Revenue is expected to decrease by -20.20% on average over the next years. This is quite bad
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DCGO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.64 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -42.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.8709
-0.03 (-2.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners50.6%
Inst Owner Change-0.32%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap85.18M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.81 (222.65%)
Short Float %5.46%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)0%
PT rev (3m)-10.57%
EPS NQ rev (1m)-10.98%
EPS NQ rev (3m)-21.34%
EPS NY rev (1m)-13.68%
EPS NY rev (3m)-21.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.23 | ||
| P/FCF | 1.64 | ||
| P/OCF | 1.47 | ||
| P/B | 0.31 | ||
| P/tB | 0.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)0.53
FCFY60.85%
OCF(TTM)0.59
OCFY67.86%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% | ||
| FCFM | 14.08% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.73% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 1.27 |
F-Score4
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-78.42%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.22%
Revenue Next 2Y-31.84%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.23%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
What is the valuation status of DOCGO INC (DCGO) stock?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
What is the financial health of DOCGO INC (DCGO) stock?
The financial health rating of DOCGO INC (DCGO) is 7 / 10.